But what we wanted to understand is what theyre doing in the brain. Key findings GLP-1 drugs act not only on metabolic pathways but also on brain circuits linked to reward Researchers identified a pathway connecting the hindbrain, central amygdala and dopamine-producing neurons The drugs reduce not just hunger, but the desire for high-calorie, rewarding foods Findings may help explain both therapeutic benefits and side effects such as nausea or reduced pleasure Beyond appetite suppression GLP-1 receptor agonists were originally developed to treat Type 2 diabetes by improving insulin response, with weight loss emerging as a secondary benefit
Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S, Starup-Linde J
This is why I believe combining anabolic support with GLP-1 therapy is not just beneficial but essential for optimal outcomes
bei Menschen mit Histamin-Unvertrglichkeit auftreten
Neuropsychopharmacology 37:338349 Summer GJ, Romero-Sandoval EA, Bogen O, Dina OA, Khasar SG, Levine JD (2008) Proinflammatory cytokines mediating burn-injury pain
Never increase, decrease, delay, or skip doses without discussing your treatment plan with the licensed healthcare professional managing your care